BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
NEUROG3
,
Fatty acid metabolic process
,
Breast Cancer
,
Embryo
,
Alcohol
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hyperlipoproteinemia
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
APOC2
APOE
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
chylomicron
REACTOME_HDL_MEDIATED_LIPID_TRANSPORT
REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
REACTOME_LIPOPROTEIN_METABOLISM
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Mouse Phenotypes - Inborn error of metabolism
OMIM - Disorder of lipoprotein storage and metabolism
OMIM - Hyperlipidemia
Subcutaneous adipose tissue from familial combined hyperlipidemia patients
USF1 haplotype comparison in individuals with familial combined hyperlipidemia
Explore Curated Studies Results
Literature
Most Relevant Literature
Hyperlipoproteinemia (a) and Phytoestrogen Therapy in Dialysis Patients: A Review.
A case of neonatal-onset type I hyperlipoproteinemia with bloody ascites].
Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a).
Effect and significance of hyperlipoproteinemia on stent thrombosis in patients with implanted drug-…
Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoproteinaemia (a): …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Car…
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ